Join Aitia at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin
We are thrilled to announce that our CBO, Joe Donahue will be taking the stage at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin, Germany. Session title: Digital Twins Unlock the Biological Complexity of Human Disease and Will Drive the Next Wave of Breakthrough Drugs Digital Twins are computational representations of […]
Join Aitia at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine – AIPM 2023
Join us at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine on June 5, sponsored by Pfizer Inc., the Roux Institute at Northeastern University, and the American Statistical Association (ASA). At Aitia, we are excited to present a session entitled “Causal AI for Learning ‘Digital Twins’ from Human Multi-Omic Data for Drug […]
Meet us at Bio-IT World Conference in Boston
We are thrilled to announce that Joe Donahue will be chairing a session entitled “Discover Novel Drug Candidates to Produce Better Precision Medicines” at the Bio-IT World Conference on May 18th at 10:20 ET, as part of the “AI for Drug Discovery and Development” track. The AI for Drug Discovery and Development track is an […]
Join Aitia at Charles River’s sixth Annual World Congress
We are excited to announce that Colin Hill will be speaking at Charles River’s sixth Annual World Congress on May 11, 2023, in Cambridge, MA. Colin’s session will focus on “Al and Digital Twins to Drive the Next Generation of Drug Discovery and Development”. The presentation will be followed by a fireside chat with Julie […]
Join Aitia and our Partner GAP at the American Academy of Neurology Annual Meeting 2023
We are excited to announce our attendance at the American Academy of Neurology Annual Meeting 2023, which will be held in Boston. As we look forward to this event, we are also pleased to be joined by our strategic partner the Global Alzheimer’s Platform Foundation (GAP). Together, we are committed to advancing the field of […]
Join Aitia at the Pistoia Alliance Annual Spring Conference
We are excited to be attending the Pistoia Alliance Annual Spring Conference. This year’s theme is Collaborate to Innovate, and we can’t wait to explore the opportunities for pre-competitive collaboration in the life sciences industry. Let’s connect and discuss the challenges and possibilities for innovation and AI adoption in R&D. Come meet us there and […]
Aitia Announces Oral Poster Presentation and Abstract at AACR
Aitia is looking forward to attend this year’s American Association for Cancer Research meeting #AACR23 taking place in Orlando, Florida, on April 14-19. Our team will be presenting a poster with our new results from our Multiple Myeloma Digital Twins model. Details of the poster session: Title: Infer cancer cell gene dependency in multiple myeloma using causal AI in-silico patient […]
Aitia Announces its Participation in the Upcoming AD/PD™ 2023 in Gothenburg, Sweden
Aitia is excited to announce its participation in the upcoming AD/PD™ 2023, a global conference on Alzheimer’s and Parkinson’s Diseases, to be held in Gothenburg, Sweden from March 28 – April 1.If you are interested in learning more about Aitia’s latest breakthroughs, particularly in the field of Alzheimer’s disease, we encourage you to schedule a […]
Join Aitia at BIO-Europe Spring 2023 in Basel, Switzerland
Aitia team will be attending the 17th annual BIO-Europe Spring conference in Basel, Switzerland, from March 20 to March 22, 2023. This event brings together over 2,800 executives from the biopharmaceutical industry, and we are excited to meet with fellow industry leaders to exchange ideas, forge new partnerships, and advance our shared goal of improving […]
Richard Harrison to Present at the Lab of the Future Congress
The Lab of the Future Congress USA is returning to Boston on March 9th and 10th 2023, and Team Aitia will be there to share our expertise on how Digital Twins are revolutionizing the drug discovery process and validating novel targets. Don’t miss the opportunity to attend our informative session on March 10th at 11:50 […]